Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 11:41AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.16 Insider Own18.15% Shs Outstand42.41M Perf Week67.93%
Market Cap206.54M Forward P/E- EPS next Y-1.19 Insider Trans0.00% Shs Float34.72M Perf Month80.37%
Income-56.85M PEG- EPS next Q-0.23 Inst Own75.90% Short Float11.55% Perf Quarter815.41%
Sales0.00M P/S- EPS this Y64.89% Inst Trans-3.41% Short Ratio1.38 Perf Half Y537.43%
Book/sh1.47 P/B3.31 EPS next Y16.99% ROA-53.76% Short Interest4.01M Perf Year319.83%
Cash/sh2.24 P/C2.18 EPS next 5Y- ROE-87.77% 52W Range0.36 - 5.89 Perf YTD806.89%
Dividend Est.- P/FCF- EPS past 5Y- ROI-61.54% 52W High-17.32% Beta1.35
Dividend TTM- Quick Ratio12.99 Sales past 5Y0.00% Gross Margin- 52W Low1241.60% ATR (14)0.46
Dividend Ex-Date- Current Ratio12.99 EPS Y/Y TTM41.43% Oper. Margin0.00% RSI (14)78.56 Volatility20.88% 12.81%
Employees33 Debt/Eq0.48 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price6.50
Option/ShortNo / Yes LT Debt/Eq0.48 EPS Q/Q84.96% Payout- Rel Volume0.59 Prev Close5.01
Sales Surprise- EPS Surprise19.35% Sales Q/Q- EarningsNov 02 BMO Avg Volume2.90M Price4.87
SMA2054.68% SMA50110.80% SMA200232.97% Trades Volume629,355 Change-2.79%
Date Action Analyst Rating Change Price Target Change
Mar-01-24Initiated JMP Securities Mkt Outperform $7
May-30-23Upgrade SVB Securities Market Perform → Outperform $5 → $8
Dec-23-21Initiated H.C. Wainwright Buy $12
Today 07:30AM
Feb-28-24 07:30AM
Feb-23-24 09:17AM
Feb-22-24 07:30AM
Jan-22-24 07:30AM
10:25AM Loading…
Jan-09-24 10:25AM
Jan-05-24 07:30AM
Nov-22-23 07:30AM
Nov-02-23 09:40AM
Sep-05-23 07:30AM
Aug-16-23 07:30AM
Aug-03-23 07:30AM
Jul-13-23 08:00AM
Jun-08-23 10:41PM
04:01PM Loading…
Jun-03-23 09:00AM
May-19-23 06:54AM
May-15-23 07:30AM
Apr-26-23 04:05PM
Apr-17-23 10:15AM
Mar-23-23 09:40AM
Mar-14-23 04:30PM
Mar-09-23 07:30AM
Mar-01-23 07:00AM
Feb-08-23 07:00AM
Jan-09-23 07:30AM
Jan-06-23 08:15AM
Nov-30-22 07:30AM
Nov-03-22 07:30AM
09:30AM Loading…
Aug-12-22 09:30AM
Aug-04-22 07:30AM
Aug-03-22 08:00AM
Jul-28-22 08:50AM
Jul-14-22 08:45AM
Jun-01-22 07:30AM
May-26-22 05:05PM
May-25-22 07:30AM
May-05-22 07:30AM
Apr-27-22 10:05AM
Mar-24-22 01:12PM
Mar-14-22 07:00AM
Mar-03-22 07:30AM
Mar-01-22 07:00AM
Jan-10-22 07:00AM
Jan-06-22 08:00AM
Jan-05-22 08:00AM
Dec-16-21 09:14AM
Nov-18-21 08:00AM
Nov-12-21 07:30AM
Oct-20-21 07:00AM
Oct-14-21 07:00AM
Sep-25-21 09:52AM
Sep-07-21 07:00AM
Aug-12-21 04:05PM
Aug-04-21 07:00AM
Jun-24-21 08:44PM
Elevation Oncology, Inc. is a precision oncology company. It focuses on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm's program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.